# Vitamin C & Thiamine to Treat Sepsis and Septic Shock

> **NCT03592277** · PHASE2 · COMPLETED · sponsor: **Trinity Health Of New England** · enrollment: 120 (actual)

## Conditions studied

- Sepsis
- Septic Shock

## Interventions

- **DRUG:** Vitamin C
- **DRUG:** Vitamin B1

## Key facts

- **NCT ID:** NCT03592277
- **Lead sponsor:** Trinity Health Of New England
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-09-14
- **Primary completion:** 2021-02-22
- **Final completion:** 2021-02-22
- **Target enrollment:** 120 (ACTUAL)
- **Last updated:** 2022-09-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03592277

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03592277, "Vitamin C & Thiamine to Treat Sepsis and Septic Shock". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03592277. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*